Annual Accounts Payable
$189.40 K
+$18.50 K+10.83%
December 1, 2023
Summary
- As of February 7, 2025, BRTX annual accounts payable is $189.40 thousand, with the most recent change of +$18.50 thousand (+10.83%) on December 1, 2023.
- During the last 3 years, BRTX annual accounts payable has risen by +$70.50 thousand (+59.29%).
- BRTX annual accounts payable is now -92.57% below its all-time high of $2.55 million, reached on December 31, 2015.
Performance
BRTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$401.40 K
+$185.50 K+85.92%
September 1, 2024
Summary
- As of February 7, 2025, BRTX quarterly accounts payable is $401.40 thousand, with the most recent change of +$185.50 thousand (+85.92%) on September 1, 2024.
- Over the past year, BRTX quarterly accounts payable has increased by +$174.00 thousand (+76.52%).
- BRTX quarterly accounts payable is now -85.23% below its all-time high of $2.72 million, reached on September 30, 2017.
Performance
BRTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BRTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.8% | +76.5% |
| 3 y3 years | +59.3% | +690.2% |
| 5 y5 years | -90.0% | +690.2% |
BRTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +272.8% | -14.3% | +690.2% |
| 5 y | 5-year | -90.3% | +272.8% | -80.4% | +1154.4% |
| alltime | all time | -92.6% | +272.8% | -85.2% | +1154.4% |
BioRestorative Therapies Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $401.40 K(+85.9%) |
| Jun 2024 | - | $215.90 K(-6.5%) |
| Mar 2024 | - | $230.90 K(+21.9%) |
| Dec 2023 | $189.40 K(+10.8%) | $189.40 K(-16.7%) |
| Sep 2023 | - | $227.40 K(-17.6%) |
| Jun 2023 | - | $276.00 K(+198.1%) |
| Mar 2023 | - | $92.60 K(-45.8%) |
| Dec 2022 | $170.90 K(+236.4%) | $170.90 K(-63.5%) |
| Sep 2022 | - | $468.50 K(+23.9%) |
| Jun 2022 | - | $378.20 K(+76.8%) |
| Mar 2022 | - | $213.90 K(+321.1%) |
| Dec 2021 | $50.80 K(-57.3%) | $50.80 K(-59.2%) |
| Sep 2021 | - | $124.60 K(+27.5%) |
| Jun 2021 | - | $97.70 K(-60.2%) |
| Mar 2021 | - | $245.70 K(+106.6%) |
| Dec 2020 | $118.90 K(-93.9%) | $118.90 K(+134.5%) |
| Sep 2020 | - | $50.70 K(+58.4%) |
| Jun 2020 | - | $32.00 K(-98.4%) |
| Mar 2020 | - | $2.05 M(+4.8%) |
| Dec 2019 | $1.95 M(+3.2%) | $1.95 M(+12.1%) |
| Sep 2019 | - | $1.74 M(+14.2%) |
| Jun 2019 | - | $1.53 M(-2.6%) |
| Mar 2019 | - | $1.57 M(-17.2%) |
| Dec 2018 | $1.89 M(-22.9%) | $1.89 M(-10.3%) |
| Sep 2018 | - | $2.11 M(-7.2%) |
| Jun 2018 | - | $2.28 M(-4.6%) |
| Mar 2018 | - | $2.39 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $2.45 M(+7.5%) | $2.45 M(-9.7%) |
| Sep 2017 | - | $2.72 M(+10.2%) |
| Jun 2017 | - | $2.47 M(+8.0%) |
| Mar 2017 | - | $2.28 M(0.0%) |
| Dec 2016 | $2.28 M(-10.4%) | $2.28 M(+14.5%) |
| Sep 2016 | - | $1.99 M(-3.6%) |
| Jun 2016 | - | $2.07 M(-5.7%) |
| Mar 2016 | - | $2.19 M(-13.9%) |
| Dec 2015 | $2.55 M(+129.2%) | $2.55 M(+20.8%) |
| Sep 2015 | - | $2.11 M(+20.8%) |
| Jun 2015 | - | $1.75 M(+38.0%) |
| Mar 2015 | - | $1.27 M(+13.8%) |
| Dec 2014 | $1.11 M(-12.4%) | $1.11 M(+43.6%) |
| Sep 2014 | - | $774.10 K(-13.4%) |
| Jun 2014 | - | $893.40 K(-25.7%) |
| Mar 2014 | - | $1.20 M(-5.3%) |
| Dec 2013 | $1.27 M(+64.6%) | $1.27 M(+9.8%) |
| Sep 2013 | - | $1.16 M(+15.3%) |
| Jun 2013 | - | $1.00 M(+29.7%) |
| Mar 2013 | - | $773.30 K(+0.2%) |
| Dec 2012 | $771.40 K(+81.0%) | $771.40 K(+10.2%) |
| Sep 2012 | - | $699.80 K(+59.0%) |
| Jun 2012 | - | $440.00 K(-40.5%) |
| Mar 2012 | - | $739.20 K(+73.4%) |
| Dec 2011 | $426.20 K(+166.0%) | $426.20 K(-35.3%) |
| Sep 2011 | - | $658.30 K(+310.9%) |
| Dec 2010 | $160.20 K | $160.20 K |
FAQ
- What is BioRestorative Therapies annual accounts payable?
- What is the all time high annual accounts payable for BioRestorative Therapies?
- What is BioRestorative Therapies annual accounts payable year-on-year change?
- What is BioRestorative Therapies quarterly accounts payable?
- What is the all time high quarterly accounts payable for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly accounts payable year-on-year change?
What is BioRestorative Therapies annual accounts payable?
The current annual accounts payable of BRTX is $189.40 K
What is the all time high annual accounts payable for BioRestorative Therapies?
BioRestorative Therapies all-time high annual accounts payable is $2.55 M
What is BioRestorative Therapies annual accounts payable year-on-year change?
Over the past year, BRTX annual accounts payable has changed by +$18.50 K (+10.83%)
What is BioRestorative Therapies quarterly accounts payable?
The current quarterly accounts payable of BRTX is $401.40 K
What is the all time high quarterly accounts payable for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly accounts payable is $2.72 M
What is BioRestorative Therapies quarterly accounts payable year-on-year change?
Over the past year, BRTX quarterly accounts payable has changed by +$174.00 K (+76.52%)